Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
|
|
VOLITIONRX LTD (VNRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/10/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 11/10/2021 |
8-K
| Quarterly results |
| 08/11/2021 |
8-K
| Quarterly results |
| 05/11/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Quarterly results |
| 08/13/2020 |
8-K
| Quarterly results |
| 05/07/2020 |
8-K
| Quarterly results |
| 11/12/2019 |
8-K
| Quarterly results |
| 08/12/2019 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Second Quarter 2019 Earnings and Business Update Conference Call  Date: Tuesday, August 13, 2019  Time: 8:30 a.m. U.S. Eastern time  U.S. & Canada Dial-in: 1-877 407 9716  U.K. Dial-in: 0 800 756 3429  Toll/International: 1-201 493 6779  Conference ID: 13693585 Cameron Reynolds, President and Chief Executive Officer of Volition, will host the call along with David Vanston, Chief Financial Officer and Scott Powell, Executive Vice President, Investor Relations. The call will provide an update on recent developments and Volition’s activities, including details of new and ongoing clinical trials, important events which have taken place in the second quarter of 2019, and milestones for 2019 and beyond. About Volition Volition is..." |
|
| 05/08/2019 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Thursday, May 9 at 8:30 a.m. U.S. Eastern Time AUSTIN, Texas, May 8, 2019 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the first quarter ended March 31, 2019. Volition management will host a conference call tomorrow, May 9, at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below. Cameron Reynolds, President and Chief Executive Officer of Volition, upon releasing these results, commented, “I could not be more proud of our dedicated team at Volition, and the ground-breaking work they are doing. During the first quarter, we, together with ou..." |
|
| 11/07/2018 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update ISNES, Belgium, November 7, 2018 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the quarter ended September 30, 2018. Volition management will host a conference call to discuss these results and provide a further business update tomorrow, November 8, at 8:30 AM U.S. Eastern Time. Cameron Reynolds, President and Chief Executive Officer of Volition, said, “We have had numerous highlights this quarter, with good progress being made on many fronts demonstrating the diverse nature of our platform technology. From a financial perspective I am delighted that we have strengthened the balance sheet in three ways: most importantly with completion of a private placeme..." |
|
| 08/13/2018 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update ISNES, Belgium, August 13, 2018 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the quarter ended June 30, 2018. Volition management will host a conference call to discuss these results and provide a further business update tomorrow, August 14, at 8:30 AM U.S. Eastern Time. Cameron Reynolds, President and Chief Executive Officer of Volition, said, “We have had numerous highlights this quarter, with strong progress being made on many fronts. I am delighted with the broad strength of new talent in our team, especially the growth in our research and development team in Belgium who are hard at work on the considerable project of turning our assays into robust p..." |
|
| 05/10/2018 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update ISNES, Belgium, May 10, 2018 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the first quarter ended March 31, 2018. Volition management will host a conference call tomorrow, May 11, at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below. Mr. Cameron Reynolds, President and Chief Executive Officer of Volition, said, “We have made great progress this quarter, moving our clinical assay development strongly forward and broadening our potential revenue base with our recently announced exclusive global license, manufacturing, sales and distribution agreement with Active Motif for a range of research use only kits.” Mr...." |
|
| 11/09/2017 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update ISNES, Belgium, November 9, 2017 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the third quarter ended September 30, 2017. Volition management will host a conference call tomorrow, November 10, at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below. Mr. Cameron Reynolds, President and Chief Executive Officer of Volition, said, “We have made fantastic progress this quarter, moving our clinical product development strongly forward in Asia, Europe and the U.S, and broadening our potential revenue base with our recently announced research kit sales. We have further expanded our talented scientific team, with four new..." |
|
| 08/09/2017 |
8-K
| Quarterly results|
Docs:
|
"VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update ISNES, Belgium, August 9, 2017 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the quarter ended June 30, 2017. Volition management will host a conference call to discuss these results and provide a further business update tomorrow, August 10, 2017 at 8:30 AM U.S. Eastern Time. Cameron Reynolds, President and Chief Executive Officer of Volition, said, “We have had numerous highlights this quarter, with strong progress being made on many fronts. I am delighted with the growing strength of new talent in our team, especially the growth in our Research and Development Team in Belgium. We are also fortunate to be working with institutions and individuals who hav..." |
|
| 05/16/2017 |
8-K
| Form 8-K - Current report |
| 11/15/2016 |
8-K
| Form 8-K - Current report |
| 08/16/2016 |
8-K
| Quarterly results, Conference call transcript |
| 05/19/2016 |
8-K
| Quarterly results, Conference call transcript |
|
|